← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$716K

Shares

16,000

Price

$45

Filed

Sep 30

Insider

Name

Fust Matthew K

Title

CIK

0001397266

Roles

Director

Transaction Details

Transaction Date

2025-09-26

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

22,836

Footnotes

The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. | The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $44.75 per share. | 1/3rd of the options vested on February 16, 2019, and 1/36th of the options vested monthly thereafter.

Filing Info

Accession No.

0001658247-25-000010

Form Type

4

Issuer CIK

0001658247

Fust Matthew K's History

Date Ticker Type Value
2025-09-26 CRNX M $19K
2025-09-26 CRNX $716K
2025-09-26 CRNX M $0
2025-06-11 CRNX A $0
2025-06-11 CRNX A $0
2025-06-10 ATRA A $0
2025-05-28 NMRA D
2025-05-28 NMRA D
2025-05-28 NMRA D
2025-05-28 NMRA A

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08